Pharma Commons
  • Home
  • About
  • Company List
  • Contact

eli lilly

Lilly drug fails to improve survival in breast cancer trial

September 26, 2013 Reuters: Health News Eli Lilly

(Reuters) – Eli Lilly and Co will not seek approval for one of its most promising experimental drugs for treating breast cancer after it failed in a late-stage trial, denting investor hopes for one of…

Continue reading


An Experimental Lilly Cancer Drug Misses A Lucrative Target

September 26, 2013 Pharmalot Eli Lilly

In a setback to Eli Lilly, a late-stage study found that a closely watched experimental drug failed to meet its primary endpoint in combating breast cancer. Although expectations on Wall Street had al…

Continue reading


In another stinging setback, Eli Lilly’s ramucirumab fails PhIII breast cancer study

September 26, 2013 FierceBiotech News Eli Lilly

The crucial late-stage failure–ramucirumab for breast cancer has been considered one of the pharma giant’s top Phase III prospects–scuttles one of Eli Lilly’s chief hopes for a major new drug approv…

Continue reading


Lilly drug fails in breast cancer, succeeds in gastric cancer

September 26, 2013 Reuters: Healthcare Eli Lilly

Sept 26 (Reuters) – Eli Lilly and Co said its experimental cancer drug failed to improve the survival among breast cancer patients without their cancer worsening in a late-stage trial.

Continue reading


Posts navigation

Older posts

Receive a daily news digest

Enter your email address:

Search the archive

Search for:

Company list

Browse by tags

Abbott abbott laboratories Amgen astrazeneca astrazeneca plc Bayer biogen idec boehringer ingelheim breast cancer bristol myers bristol myers squibb bristol myers squibb company cancer drug diabetes drug eli lilly eli lilly and company food and drug administration genepool gilead sciences gilead sciences inc glaxosmithkline glaxosmithkline plc gsk latest biotech news Lilly lilly and company london reuters Merck merck kgaa merck serono Myers Nordisk Novartis novartis ag novo nordisk pfizer pfizer inc Pharma PLC PRNewswire reuters Roche roche holding ag rsquo sanofi
dazzling Theme by Colorlib Powered by WordPress